ClearPoint Neuro, Inc.
CLPT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001285550
No open-market purchases or sales by ClearPoint Neuro, Inc. insiders were filed in the last 90 days; 128 institutions reported holding it in 13F filings for Q2 2026, worth $247.8M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in ClearPoint Neuro, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- +12 vs. Q4 2024
- Shares held
- 8.19M
- +587.7K (+7.7%) vs. Q4 2024
- Total value
- $97.5M
- −$19.5M (−16.6%) vs. Q4 2024
- New holders
- 23
- 29 more added
- Sold out
- 11
- 31 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 128 | $247.8M |
| Q1 2026 | 118 | $118.3M |
| Q4 2025 | 118 | $154.6M |
| Q3 2025 | 107 | $222.7M |
| Q2 2025 | 96 | $109.3M |
| Q1 2025 | 101 | $97.5M |
| Q4 2024 | 89 | $117.0M |
| Q3 2024 | 78 | $76.5M |
| Q2 2024 | 86 | $38.0M |
| Q1 2024 | 81 | $51.3M |
| Q4 2023 | 71 | $42.7M |
| Q3 2023 | 63 | $29.8M |
| Q2 2023 | 60 | $42.0M |
| Q1 2023 | 60 | $38.9M |
| Q4 2022 | 62 | $36.0M |
| Q3 2022 | 56 | $39.6M |
| Q2 2022 | 50 | $45.4M |
| Q1 2022 | 64 | $49.5M |
| Q4 2021 | 67 | $53.5M |
| Q3 2021 | 69 | $97.5M |
| Q2 2021 | 76 | $102.3M |
| Q1 2021 | 50 | $65.6M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding ClearPoint Neuro, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,283,978 | $15.3M | 0.00% | +35,585+2.9% | Added |
| Invesco Ltd. | 0 | $0 | 0.00% | −247,977−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −54,387−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −21,396−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −21,114−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −14,339−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −10,314−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −10,109−100.0% | Sold out |
| Oarsman Capital, Inc. | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −2,050−100.0% | Sold out |
| POM Investment Strategies, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |